Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-07-05T21:42:21.038Z Has data issue: false hasContentIssue false
  • English
  • Français

Recent research on the causes of Alzheimer's disease

Published online by Cambridge University Press:  28 February 2007

M. J. Rowan
M. J. Rowan
Affiliation:
Department of Pharmacology and Therapeutics, Trinity College, Dublin 2, Republic ofIreland
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposium on ‘Alzheimer's disease and dietary aluminium’
Information
Proceedings of the Nutrition Society , Volume 52 , Issue 1 , February 1993 , pp. 255 - 262
Copyright
Copyright © The Nutrition Society 1993

References

REFERENCES

Alzheimer, A. (1907). On a peculiar disease of the cerebral cortex. (Uber eine eigenartige Erkrankung der Hirnrinde.) Translation by R. H. Wilkins & I. A. Brody (1969). Archives of Neurology 21, 109–110.Google Scholar
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R. & van Hoesen, G. W. (1991). The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1, 103–116.CrossRefGoogle ScholarPubMed
Blessed, G., Tomlinson, B. E. & Roth, M. (1968). The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. British Journal of Psychiatry 114, 797–811.CrossRefGoogle ScholarPubMed
Braak, H. & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 82, 239–259.CrossRefGoogle ScholarPubMed
Candy, J. M., McArthur, F. K., Oakley, A. E., Taylor, G. A., Chen, C. P. L.-H., Mountfort, S. A., Thompson, J. E., Chalker, P. R., Bishop, H. E., Beyreuther, K., Perry, G., Ward, M. K., Martyn, C. N. & Edwardson, J. A. (1992). Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure. Journal of Neurological Sciences 107, 210–218.CrossRefGoogle ScholarPubMed
Castano, E. M., Wisniewski, T. & Frangione, B. (1991). Inherited amyloids of the nervous system. Current Opinion in Neurobiology 1, 448–454.CrossRefGoogle ScholarPubMed
Cowburn, R. F., Hardy, J. A. & Roberts, P. J. (1989). Neurotransmitter deficits in Alzheimer's disease. In Alzheimer's Disease: Towards an Understanding of the Aetiology and Pathogenesis, pp. 9–32 [Davies, D. C. editor]. London: John Libbey.Google Scholar
Crapper McLachlan, D. R., Dalton, A. J., Kruck, T. P. A., Bell, M. Y., Smith, W. L., Kalow, W. & Andrews, D. F. (1991). Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304–1308.CrossRefGoogle ScholarPubMed
Editorial (1992). Is aluminium a dementing ion? Lancet 339, 713–714.CrossRefGoogle Scholar
Ellis, W. G., McCulloch, I. R. & Corley, C. L. (1974). Presenile dementia in Down's Syndrome. Ultrastructural identity with Alzheimer's Disease. Neurology 24, 101–106.CrossRefGoogle ScholarPubMed
Estus, S., Golde, T. E., Kunishita, T., Blades, D., Lowery, D., Eisen, M., Usiak, M., Qu, X., Tabira, T., Greenberg, B. D. & Younkin, S. G. (1992). Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255, 726–728.CrossRefGoogle ScholarPubMed
Eurodem Risk Factors Research Group (1991). Risk Factors for Alzheimer's Disease: a Collaborative Re-analysis of Case-Control Studies. International Journal of Epidemiology 20, Suppl. 2.Google Scholar
Farrer, L. A., Meyers, R. H. & Cupples, L. A. (1990). Transmission and age-at-onset patterns in familial Alzheimer's disease: Evidence of heterogeneity. Neurology 40, 395–403.CrossRefGoogle ScholarPubMed
Flaten, T. P., Garrutto, R. M. & Davies, P. (1991). Desferrioxamine for Alzheimer's disease. Lancet 338, 324–326.CrossRefGoogle Scholar
Frautsch, S. A., Baird, A. & Cole, G. M. (1991). Proceedings of the National Academy of Sciences USA 88, 8362–8366.CrossRefGoogle Scholar
Giaccone, G., Tagliavini, F. & Linoli, G. (1989). Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neuroscience Letters 97, 232–238.CrossRefGoogle ScholarPubMed
Goedert, M., Crowther, R. A. & Garner, C. C. (1991 a). Molecular characterization of microtubule-associated proteins Tau and MAP2. Trends in Neuroscience 14, 193–199.CrossRefGoogle ScholarPubMed
Goedert, M., Sisodia, S. S. & Price, D. L. (1991 b). Neurofibrillary tangles and β-amyloid deposits in Alzheimer's disease. Current Opinion in Neurobiology 1, 441–447.CrossRefGoogle ScholarPubMed
Golde, T. E., Estus, S., Younkin, C. H., Delkoe, D. J. & Youngin, S. G. (1992). Science 255, 728–730.CrossRefGoogle Scholar
Hardy, J. & Allsop, D. (1991). Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends in Pharmacological Sciences 12, 383–388.CrossRefGoogle ScholarPubMed
Hardy, J. A. & Higgins, G. A. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184–185.CrossRefGoogle ScholarPubMed
Henderson, A. S. (1986). The epidemiology of Alzheimer's Disease. British Medical Bulletin 41, 3–10.CrossRefGoogle Scholar
Hyman, B. T. & Mann, D. M. A. (1991). Alzheimer-type pathological changes in Down's syndrome individuals of various ages. In Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies, pp. 106–113 [Iqbal, K. McLachlan, D. R. C. Winblat, B. and Wismewski, H. M. editors]. Chichester: John Wiley & Sons.Google Scholar
Hyman, B. T., Van Hoesen, G. W., Kromer, I. J. & Damasio, A. R. (1986). Perforant pathway changes and the memory impairment of Alzheimer's disease. Annals of Neurology 20, 472–481.CrossRefGoogle ScholarPubMed
Joachim, C. L., Morris, J. H. & Selkoe, D. J. (1988). Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Annals of Neurology 24, 50–56.CrossRefGoogle ScholarPubMed
Klatzo, I., Wisniewski, H. & Streicher, E. (1965). Experimental production of neurofibrillary degeneration. I. Light microscopic observations. Journal of Neurobiology and Experimental Neurology 24, 187–199.Google ScholarPubMed
Kowall, N. W., Beal, M. F., Busciglio, J., Duffy, L. K. & Yankner, B. A. (1991). An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P. Proceedings of the National Academy of Sciences USA 88, 7247–7251.CrossRefGoogle Scholar
Marottta, C. A., Majocha, R. E. & Tate, B. (1992). Molecular and cellular biology of Alzheimer amyloid. Journal of Molecular Neuroscience 3, 111–125.CrossRefGoogle Scholar
O'Neill, D., Condren, L., O'Kelly, F., King, A., Young, M., Walsh, J. B. & Coakley, D. (1988). Cognitive impairment in the elderly. Irish Medical Journal 81, 11–13.Google ScholarPubMed
Pike, G. J., Walencewicz, A. J., Glabe, C. G. & Cotman, C. W. (1991). In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Research 563, 311–314.CrossRefGoogle ScholarPubMed
Price, J. L., Davies, P. B., Morris, J. C. & White, D. L. (1991). The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiology & Aging 12, 295–312.CrossRefGoogle ScholarPubMed
Quon, D., Wang, Y., Catalano, R., Scardina Marian, J., Murakami, K. & Cordell, B. (1991). Formation of β-amyloid deposits in brains in transgenic mice. Nature 352, 239–241.CrossRefGoogle ScholarPubMed
Richards, S.-J., Waters, J. J., Abraham, C., Beyreuther, K., Masters, C. L., Wischik, C. & Dunnett, S. B. (1991). Transplants of Mourse Trisomy 16 Hippocampus Provide a Model of Alzheimer's Disease Neuropathology. Embo Journal 10, 297–303.CrossRefGoogle Scholar
Royal College of Physicians (1981). Report of the Royal College of Physicians on Organic Mental Impairment in the Elderly. Journal of the Royal College of Physicians, London 15, 4–29.Google Scholar
Royston, M. C., Rothwell, N. J. & Roberts, G. W. (1992). Alzheimer's disease: pathology to potential treatments? Trends in Pharmacological Sciences 13, 131–133.CrossRefGoogle ScholarPubMed
Selkoe, D. J. (1991). The molecular pathology of Alzheimer's disease. Neuron 6, 487–498.CrossRefGoogle ScholarPubMed
Van der Voet, G. B., Marani, E. & de Wolff, F. A. (1991). Aluminium neurotoxicity. In Histo- and Cytochemistry as a Tool in Environmental Toxicology. Progress in Histo- and Cytochemistry, vol. 23, pp. 235–242 [Graumann, W. and Drukker, J., editors]. Stuttgart: Gustav Fischer Verlag.Google Scholar
Van Nostrand, W. E., Wagner, S. L., Shankle, W. R., Farrow, J. S., Dick, M., Rozemuller, J. M., Kuiper, M. A., Walters, E. C., Zimmerman, J. & Cotman, C. W. (1992). Decreased levels of soluble amyloid β-protein precursor in cerebrospinal fluid of Alzheimer disease patients. Proceedings of the National Academy of Sciences USA 89, 2551–2554.CrossRefGoogle ScholarPubMed
Walton, J. (1991). Alzheimer's Disease and the Environment. Royal Society of Medicine Round Table Series no. 26. London: Royal Society of Medicine Services.Google Scholar
Williams, R. J. P. (1992). Aluminium in Biology and Medicine. Ciba Foundation Symposium no. 169. Chichester: John Wiley & Sons Ltd.Google Scholar
Wischik, C. M. (1991). Molecular neuropathology of Alzheimer's disease. In Carers, Professionals and Alzheimer's Disease, pp. 239–251 [O'Neill, D., editor]. London: John Libbey.Google Scholar
Yankner, B. A., Duffy, L. K. & Kirschner, D. A. (1990). Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides. Science 250, 279–282.CrossRefGoogle ScholarPubMed
Younkin, S. G. (1991). Processing of the Alzheimer's Disease BA4 Amyloid Protein Precursor (APP). Brain Pathology 1, 253–262.CrossRefGoogle Scholar